CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 300 enrolled
Drug / intervention
iNSC and Adherence supporter trainingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04330989
NCT04330989N/ACompleted

UNCPMZ 41901 - An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women: a Pilot Study

University of North Carolina, Chapel Hill·interventional·Posted Apr 2, 2020·Updated Jan 11, 2023

In Brief

A clinical study evaluating iNSC and Adherence supporter training for HIV-1-infection and Antenatal Care. Completed, enrolled 300 participants across 1 site.

Detailed Summary

This study is composed of two parallel, pilot randomized groups that will obtain preliminary data about the the acceptability, fidelity, and clinical outcomes associated with a multi-component adherence support strategy for HIV treatment and prevention among pregnant and breastfeeding women. The study will take place in Lilongwe, Malawi.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesMalawi

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedApr 2, 2020
Enrollment StartMar 1, 2020
Primary CompletionFeb 10, 2022
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 6.3 years ago

Interventions

iNSC and Adherence supporter trainingbehavioral

Integrated next step counseling: iNSC is a structured, patient-centered approach informed by motivational interviewing techniques, which aims to foster an environment for joint-problem solving in order that the participant may identify their individual needs to increase or sustain sexual health through biomedical and non-biomedical approaches. iNSC frames the counselling sessions as a non-judgmental discussion to explore the facilitators and challenges to sexual health and medication adherence. Adherence supporter training: Participants will be asked to identify a partner, family member, or friend to whom they are willing to disclose their HIV status (for HIV-positive women) or their intent to initiate PrEP (for HIV-negative women). Participants may also select a clinic-based peer to serve this adherence supporter role. Trainings will emphasize basic HIV knowledge, importance of antiretroviral adherence, potential drug side effects, and practical strategies for supporting adherence.